Biointron

About

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

Shanghai,Shanghai,China
251 - 500

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: ¥500M
Industries: Biotechnology,Health Care,Medical
Founded date: Jan 1, 2012
Number Of Employee: 251 - 500
Operating Status: Active
Legal Name: Biointron Biological Inc.

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

¥500M

Biointron has raised a total of ¥500M in funding over 2 rounds. Their latest funding was raised on Sep 2, 2022 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Sep 2, 2022	Series B	¥500M	13	—	—	Detail
Jul 28, 2021	Series A	—	1	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

13

Biointron is funded by 13 investors. West Shanghai Group and Joy Time are the most recent investors.

Investor Name	Lead Investor	Funding Round
West Shanghai Group	—	Series B
Joy Time	—	Series B
Jifeng Ventures	—	Series B
ALAN AMC	—	Series B
BeFor Capital	—	Series B
Co-Stone Venture Capital	—	Series B
CS Capital	—	Series B
Furong Capital	—	Series B
Gaorong Capital	—	Series B
GOVTOR	—	Series B